[Local tumor control of metastatic Merkel cell carcinoma in a 90-year-old woman].

4区 医学 Q3 Medicine Hautarzt Pub Date : 2021-12-01 Epub Date: 2021-03-24 DOI:10.1007/s00105-021-04799-0
Katja Dicke, Vasileios Dervenis, Axel Hauschild, Thomas Dirschka
{"title":"[Local tumor control of metastatic Merkel cell carcinoma in a 90-year-old woman].","authors":"Katja Dicke,&nbsp;Vasileios Dervenis,&nbsp;Axel Hauschild,&nbsp;Thomas Dirschka","doi":"10.1007/s00105-021-04799-0","DOIUrl":null,"url":null,"abstract":"<p><p>Merkel cell carcinoma (MCC) is a rare and aggressive form of skin cancer. Many people suffer early local recurrences and distant metastases. The anti-PDL1 (PDL1: programmed death ligand 1) antibody avelumab has been approved as first-line treatment for advanced MCC in Europe. It is also an alternative treatment for old and multimorbid patients.</p>","PeriodicalId":12970,"journal":{"name":"Hautarzt","volume":"72 12","pages":"1090-1093"},"PeriodicalIF":0.0000,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s00105-021-04799-0","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hautarzt","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00105-021-04799-0","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/3/24 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Merkel cell carcinoma (MCC) is a rare and aggressive form of skin cancer. Many people suffer early local recurrences and distant metastases. The anti-PDL1 (PDL1: programmed death ligand 1) antibody avelumab has been approved as first-line treatment for advanced MCC in Europe. It is also an alternative treatment for old and multimorbid patients.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[1例90岁妇女转移性默克尔细胞癌的局部肿瘤控制]。
默克尔细胞癌(MCC)是一种罕见的侵袭性皮肤癌。许多人出现早期局部复发和远处转移。抗PDL1 (PDL1:程序性死亡配体1)抗体avelumab已在欧洲被批准作为晚期MCC的一线治疗药物。它也是老年和多病患者的替代治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Hautarzt
Hautarzt 医学-皮肤病学
CiteScore
1.40
自引率
0.00%
发文量
93
审稿时长
4-8 weeks
期刊介绍: Der Hautarzt is an internationally recognized journal informing all dermatologists working in practical or clinical environments about important developments in the field of dermatology including allergology, venereology and related areas. Comprehensive reviews on a specific topical issue focus on providing evidenced based information on diagnostics and therapy. Freely submitted original papers allow the presentation of important clinical studies and serve the scientific exchange. Case reports feature interesting cases and aim at optimizing diagnostic and therapeutic strategies. Review articles under the rubric "Continuing Medical Education" present verified results of scientific research and their integration into daily practice.
期刊最新文献
Lanadelumab [Grey discoloration of the skin in a female goldsmith]. [Chronic brachioradial pruritus in cervical spine meningioma]. Innovative eCME courses-an approach with tangible augmented reality. Masern – auch bei Exanthemen nach Fernreisen daran denken
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1